Efficacy and Safety of Secukinumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa

NCT06926192 · clinicaltrials.gov ↗

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Hidradenitis Suppurativa (HS)
Hidradenitis Suppurativa (Acne Inversa)
Secukinumab

Interventions

COMBINATION_PRODUCT: Surgery combined with secukinumab

Sponsor

Peking Union Medical College